Coppock, D.; Violet, P.-C.; Vasquez, G.; Belden, K.; Foster, M.; Mullin, B.; Magee, D.; Mikell, I.; Shah, L.; Powers, V.;
et al. Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial. Life 2022, 12, 453.
https://doi.org/10.3390/life12030453
AMA Style
Coppock D, Violet P-C, Vasquez G, Belden K, Foster M, Mullin B, Magee D, Mikell I, Shah L, Powers V,
et al. Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial. Life. 2022; 12(3):453.
https://doi.org/10.3390/life12030453
Chicago/Turabian Style
Coppock, Dagan, Pierre-Christian Violet, Gustavo Vasquez, Katherine Belden, Michael Foster, Bret Mullin, Devon Magee, Isabelle Mikell, Lokesh Shah, Victoria Powers,
and et al. 2022. "Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial" Life 12, no. 3: 453.
https://doi.org/10.3390/life12030453
APA Style
Coppock, D., Violet, P.-C., Vasquez, G., Belden, K., Foster, M., Mullin, B., Magee, D., Mikell, I., Shah, L., Powers, V., Curcio, B., Monti, D., & Levine, M.
(2022). Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial. Life, 12(3), 453.
https://doi.org/10.3390/life12030453